These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11311657)

  • 1. Molecular markers predictive of response to chemotherapy in gastrointestinal tumors.
    Catalano V; Baldelli AM; Giordani P; Cascinu S
    Crit Rev Oncol Hematol; 2001 May; 38(2):93-104. PubMed ID: 11311657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Predictive and prognostic factors in the neoadjuvant/adjuvant therapy of gastrointestinal tumors: wishful thinking or reality?].
    Vallböhmer D; Lenz HJ
    Zentralbl Chir; 2006 Apr; 131(2):148-56. PubMed ID: 16612782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymidylate synthase expression and prognosis of patients with gastrointestinal cancers receiving adjuvant chemotherapy: a review.
    Formentini A; Henne-Bruns D; Kornmann M
    Langenbecks Arch Surg; 2004 Oct; 389(5):405-13. PubMed ID: 15309542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal stromal tumors: diagnosis and treatment.
    Acín-Gándara D; Pereira-Pérez F; Castaño-Pascual A; Durán-Poveda M; Antequera-Pérez A; Miliani-Molina C
    Cir Cir; 2012; 80(1):44-51. PubMed ID: 22472152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Therapy of Gastrointestinal Stromal Tumors.
    Rutkowski P; Hompes D
    Surg Oncol Clin N Am; 2016 Oct; 25(4):735-59. PubMed ID: 27591496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular markers associated with response to chemotherapy in gastro-entero-pancreatic neuroendocrine tumors.
    O'Toole D; Couvelard A; Rebours V; Zappa M; Hentic O; Hammel P; Levy P; Bedossa P; Raymond E; Ruszniewski P
    Endocr Relat Cancer; 2010 Dec; 17(4):847-56. PubMed ID: 20570957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiotherapeutic strategies in the multimodal therapy of resectable and nonresectable pancreatic carcinoma].
    Wiegel T; Runkel N; Frommhold H; Rübe C; Hinkelbein W
    Strahlenther Onkol; 2000 Jul; 176(7):299-306. PubMed ID: 10962995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gastrointestinal stromal tumors. Analysis of 40 cases].
    García B; Ibarra J; Sola A; Diumenjo M; Binia S; Fader E
    Medicina (B Aires); 2017; 77(5):370-372. PubMed ID: 29044012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for gastrointestinal malignancy.
    Van der Veer LD; Balint JA
    Am J Gastroenterol; 1980 Jul; 74(1):40-9. PubMed ID: 7424879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy.
    Eisenberg BL; Judson I
    Ann Surg Oncol; 2004 May; 11(5):465-75. PubMed ID: 15123459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Challenge of Developing New Therapies for Childhood Cancers.
    Balis FM
    Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of gastrointestinal diffuse large B cell lymphoma in China: a 10-year retrospective study of 114 cases.
    Li X; Shen W; Cao J; Wang J; Chen F; Wang C; Zou S; Shen B; Zhao R; Li J; Shen Z
    Ann Hematol; 2012 Nov; 91(11):1721-9. PubMed ID: 22733613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant imatinib therapy for gastrointestinal stromal tumors.
    Pisters PW; Colombo C
    J Surg Oncol; 2011 Dec; 104(8):896-900. PubMed ID: 22069174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors to targeted treatment in gastrointestinal carcinomas.
    Silvestris N; Marech I; Brunetti AE; Azzariti A; Numico G; Cicero G; Delcuratolo S; De Luca R; Burz C; Lorusso V
    Cancer Biomark; 2014; 14(2-3):151-62. PubMed ID: 24878816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric/"Wildtype" gastrointestinal stromal tumors.
    Mullassery D; Weldon CB
    Semin Pediatr Surg; 2016 Oct; 25(5):305-310. PubMed ID: 27955734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical application of hyperthermia combined with anticancer drugs for the treatment of solid tumors.
    Takahashi I; Emi Y; Hasuda S; Kakeji Y; Maehara Y; Sugimachi K
    Surgery; 2002 Jan; 131(1 Suppl):S78-84. PubMed ID: 11821791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a role for surgery in patients with "unresectable" cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate?
    Scaife CL; Hunt KK; Patel SR; Benjamin RS; Burgess MA; Chen LL; Trent J; Raymond AK; Cormier JN; Pisters PW; Pollock RE; Feig BW
    Am J Surg; 2003 Dec; 186(6):665-9. PubMed ID: 14672776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The latest advances in chemotherapy for gastrointestinal cancers.
    Ohtsu A
    Int J Clin Oncol; 2003 Aug; 8(4):234-8. PubMed ID: 12955579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy.
    Saw RP; Morgan M; Koorey D; Painter D; Findlay M; Stevens G; Clarke S; Chapuis P; Solomon MJ
    Dis Colon Rectum; 2003 Feb; 46(2):192-202. PubMed ID: 12576893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.